AbbVie ABBV Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $697M-45.9% | $1.82B— | $188M-88.0% | $941M-31.5% | $1.29B-6.0% | ||
| $444M+8.3% | $157M-4.3% | $209M+15.5% | $179M-17.9% | $410M+17.8% | ||
| $3.83B+134% | $5.22B-26.0% | $7.02B+29.0% | $5.15B+127% | $1.64B-59.5% | ||
| $265M+12.8% | $329M+13.1% | $381M+53.0% | $269M+11.6% | $235M+21.8% | ||
| $0-100% | —— | —— | —— | $204M-97.8% | ||
| -$574M+21.9% | -$1.46B+21.9% | -$3.26B+60.5% | -$1.18B-7.2% | -$735M+92.3% | ||
| $3.09B+5.5% | $2.91B+5.8% | $2.91B+5.8% | $2.91B+5.8% | $2.93B+5.5% | ||
| $1.49B+54.9% | $3M-99.2% | $4M-76.5% | $12M+33.3% | $961M-27.4% | ||
| $7.99B+100% | —— | —— | —— | $3.99B-73.3% | ||
| $919M+173% | -$4.17B+39.3% | -$4.59B— | -$2.71B— | -$1.26B-112% | ||
| $4.16B+1,293% | -$400M+76.9% | -$838M+85.7% | $1.29B+126% | -$349M-107% | ||
| $3.56B+155% | $4.89B-27.6% | $6.64B+27.8% | $4.88B+141% | $1.4B-63.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AbbVie generate?
- AbbVie (ABBV) generated $21.2B in operating cash flow over the trailing twelve months.
- What is AbbVie's free cash flow?
- After $1.2B of capital expenditures, AbbVie's free cash flow was $20.0B over the trailing twelve months, up 29.9% year over year.
- Where does AbbVie's cash flow data come from?
- Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
